Invesco’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-62,863
| Closed | -$631K | – | 3968 |
|
|
2023
Q4 | $631K | Sell |
62,863
-2,263
| -3% | -$22.7K | ﹤0.01% | 3092 |
|
|
2023
Q3 | $188K | Buy |
65,126
+1,664
| +3% | +$4.79K | ﹤0.01% | 3595 |
|
|
2023
Q2 | $242K | Sell |
63,462
-15,209
| -19% | -$57.9K | ﹤0.01% | 3548 |
|
|
2023
Q1 | $146K | Buy |
+78,671
| New | +$146K | ﹤0.01% | 3651 |
|
|
2022
Q4 | – | Sell |
-93,907
| Closed | -$302K | – | 4056 |
|
|
2022
Q3 | $302K | Buy |
93,907
+352
| +0.4% | +$1.13K | ﹤0.01% | 3490 |
|
|
2022
Q2 | $515K | Buy |
93,555
+19,443
| +26% | +$107K | ﹤0.01% | 3288 |
|
|
2022
Q1 | $173K | Buy |
74,112
+34,679
| +88% | +$81K | ﹤0.01% | 3759 |
|
|
2021
Q4 | $238K | Buy |
+39,433
| New | +$238K | ﹤0.01% | 3678 |
|